Share your information on an upcoming Stock Catalyst. Please provide details (Catalyst type, and Link to information) and why you think it’s a catalyst. Sharing information is what helps us all grow, Thank you!

The more information provided, the better everyone can make a decision on the value of the information, and plan a trade.

Once you submit the information we will evaluate shortly. Thank you!

Some great catalyst are Biotechs with upcoming PDUFA dates, Clinical studies results, and Earnings reports.

Plenty of times a stock price will move into an upcoming catalyst, and provide for a great trading opportunity.

 
 

These events/catalyst/information is not verified or confirmed, nor are there any promises of accuracy. Please do your own due diligence prior to making any financial decision.

 
 


Sun Mon Tue Wed Thu Fri Sat
1
ALT Biotech Catalyst 8:00 am
ALT Biotech Catalyst
Jul 1 @ 8:00 am – Sep 30 @ 2:00 pm
ALT Biotech Catalyst
ALT – Altimmune, Inc. has three upcoming catalyst. 2 catalyst in 3Q and 1 in 4Q of 2018, and plenty of insider buying. #ALT NASOSHIELD, Anthrax vaccine – has Phase 1 data due early 3Q[...]
CRMD Phase3 Neutrolin 8:00 am
CRMD Phase3 Neutrolin
Jul 1 @ 8:00 am – Jul 15 @ 4:30 pm
CRMD Phase3 Neutrolin
CRMD, CorMedix, Inc., has an upcoming Phase3 data due 2H 2018, LOCK-IT 100 study for Neutrolin® with interim analysis due (most likely) early July 2018. https://www.marketwatch.com/story/cormedix-inc-reports-progress-on-lock–it-100-data-review-and-appoints-paul-chew-as-consultant-advisor-cmo-2018-05-29 Last Offering the company did seems to be May[...]
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
DRRX – DURECT PDUFA RBP-7000 & Remoxy 11:49 am
DRRX – DURECT PDUFA RBP-7000 & Remoxy
Jul 27 @ 11:49 am – Aug 7 @ 12:49 pm
DRRX - DURECT PDUFA RBP-7000 & Remoxy
DRRX – DURECT Corporation has 2 upcoming PDUFA dates for RBP-7000 & Remoxy. RBP-7000 FDA has set a PDUFA (Prescription Drug User Fee Act) target action date of July 28, 2018. Indivior UK Limited has a[...]
28
29
30
PGNX – Progenics Pharmaceuticals Upcoming catalysts 7:07 pm
PGNX – Progenics Pharmaceuticals Upcoming catalysts
Jul 30 @ 7:07 pm – 8:07 pm
PGNX - Progenics Pharmaceuticals Upcoming catalysts
PGNX – Progenics Pharmaceuticals has an upcoming PDUFA priority review for Azedra, and Phase3 Top-line results for z1404, a PSMA-targeted small molecule SPECT/CT imaging agent designed to visualize prostate cancer which are expected in the[...]
31